Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
01/2004
01/14/2004CN1468271A One-pack moisture-curing epoxy resin composition
01/14/2004CN1468270A One-pack moisture-curable epoxy resin composition
01/14/2004CN1468248A Use of chiral diphosphines as optically active ligands
01/14/2004CN1468228A 7-carboxy-flavone derivatives, preparation method and therapeutic use
01/14/2004CN1468102A Modified prodrug forms of ap/amp
01/14/2004CN1134448C Synthesis of ruthenium or osmium metathesis catalysts
01/14/2004CN1134411C Bicyclic amino derivatives and PGD2 antagonist containing same
01/13/2004US6677491 Fragrance delivery system for use in laundry detergent compositions including rinse-added and dryer-added fabric conditioning compositions which provides a long lasting ?freshness? or ?clean? scent to fabric.
01/13/2004US6677487 Combining a tertiary amide with a pentavalent phosphorous halide in a solvent to form an alpha - haloiminium salt and converting the alpha -haloiminium salt to the alpha -haloenamine with a base
01/13/2004US6677462 S-(+)-4-methoxy-6-phenethyl-5,6-dihydro-pyran-2-one; plant extracts for nutraceutical foods, topical ointments
01/13/2004US6677461 Ligands and asymmetric catalysts made by using the same
01/13/2004US6677374 Nervous system disorders
01/13/2004US6676929 Medical diagnosis; gadofosveset
01/13/2004CA2142597C Phosphonic diester derivatives
01/13/2004CA2053359C Heteroaroyl derivatives of monocyclic beta-lactam antibiotics
01/08/2004WO2004002995A1 Phosphoramidites for coupling oligonucleotides to [2 + 2] photoreactive groups
01/08/2004WO2004002994A2 Novel phosphonocarboxylic acid esters
01/08/2004WO2004002989A1 Process and intermediates for making non-nucleoside hiv-1 reverse transcriptase inhibitors
01/08/2004WO2004002622A1 Use of tellurium in carbon-supported, noble metal-containing catalysts for liquid phase oxidation reactions
01/08/2004WO2004002403A2 Sterols bearing pendant allosteric effectors of hemoglobin, and uses thereof
01/08/2004WO2003047515A3 P2x7 receptor antagonists
01/08/2004WO2003040159A3 Bidentate ligands for the carbonylation of unsaturated compounds
01/08/2004WO2003028628A3 Photosensitizing carbamate derivatives
01/08/2004WO2001087920A3 Ligation method and reagents to form an amide bond
01/08/2004US20040006243 Reacting a phenylketone with a silylcyanide in the presence of an asymmetric catalyst to form a siloxynitrile, and reacting the siloxynitrile with a reducing agent to obtain an aldehyde and oxidizing the aldehyde, or hydrolysis of siloxynitrile
01/08/2004US20040006242 Immunomodulatory compounds and method of use thereof
01/08/2004US20040006132 For therapy
01/08/2004US20040006131 Compounds selectively inhibiting gamma 9 delta 2 T lymphocytes
01/08/2004US20040006104 For therapy and prophylaxis of diseases and conditions associated with undesirable or abnormal inflammatory responses, such as ischemia-reperfusion injury, asthma, arthritis
01/08/2004US20040006076 Thiazolyl amide derivatives
01/08/2004US20040005984 Bridged bi-aromatic ligands, catalysts, processes for polymerizing and polymers therefrom
01/08/2004US20040005607 Bis-diazo,triaryl and aryldiazo-N-arylphenazonium quencher moieties, substituted with electron withdrawing, electron donating substituents which induce polarity in delocalized aryl/diazo ring system; use as labels attached to biomolecules
01/08/2004DE10227508A1 Säuregruppen-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung Acid group-substituted Diphenylazetidinones, processes for their preparation, pharmaceutical compositions containing them and their use
01/08/2004DE10226732A1 Mischungen aus einem Phosphonit und anderen Komponenten Mixtures of a phosphonite and other components
01/08/2004DE10226592A1 Tumorhemmende Platin(II)-oxalato-Komplexe Antitumor platinum (II) complexes -oxalato
01/08/2004CA2490931A1 Novel phosphonocarboxylic acid esters
01/08/2004CA2490133A1 Use of tellurium in carbon-supported, noble metal-containing catalysts for liquid phase oxidation reactions
01/08/2004CA2487554A1 Process and intermediates for making non-nucleoside hiv-1 reverse transcriptase inhibitors
01/07/2004EP1378532A1 Polymer containing 9-oxo-9-phosphafluorene-2,7-diyl skeleton in backbone and process for producing the same
01/07/2004EP1378166A1 Pesticide formulations containing phosphate ester surfactant and alkoxylated lignosulfonate
01/07/2004EP1377693A2 Micro-engineered reactors
01/07/2004EP1377663A2 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
01/07/2004EP1377628A1 Phosphorous-containing, organic polymerisable silanes and silicic acid polycondensates produced therewith
01/07/2004EP1377593A2 2-amino-propanol derivatives
01/07/2004EP1377556A1 Pyrazole derivatives for treating hiv
01/07/2004EP1377376A1 Catalysts for nucleophilic substitution, synthesis thereof, composition containing same and use thereof
01/07/2004EP1377290A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
01/07/2004EP1377220A1 Fluorescent cobalamins and uses thereof
01/07/2004EP1292638B1 Novel phosphorous-nitrogen compounds used as fireproofing agents in thermoplastic molding materials and the production thereof
01/07/2004CN1466620A Phosphate fluorosurfactants for use in carbon dioxide
01/07/2004CN1466589A Method for isolating harmaceutically exploitable etidronate disodium
01/07/2004CN1465582A Nucleotide analogs, medicinal compositions having same and use thereof
01/07/2004CN1465581A Organic phosphoramide hydrochloride
01/07/2004CN1465580A Simple method for synthesizing pro-drug of compete A-4
01/07/2004CN1133638C Method of extracting high-purity acephate raw powder from acephate raw oil
01/06/2004US6673955 Preparation of triethyl phosphate
01/06/2004US6673780 Such as 4-(4-(3-hydroxy-3-methyl-butane-1-sulfinylmethyl)-phenylmethanesulfinyl)-2 -methyl-butan1-ol for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
01/06/2004CA2281709C Detection of microbial metabolites
01/06/2004CA2099232C Fluoro taxols
01/02/2004EP1375506A1 High metathesis activity ruthenium and osmium metal carbene complexes
01/02/2004EP1375505A1 Optically active alkenylphosphinic acid ester and process for producing the same
01/02/2004EP1374829A1 Dental material on the basis of acryloester phosphonic acid
01/02/2004EP1373284A1 Catalysts characterized by a donor-acceptor interaction
01/02/2004EP1373280A1 Phosphonium phosphinate compounds and their preparation
01/02/2004EP1373279A1 Method for producing diphosphines and the use thereof
01/02/2004EP1373170A1 Cross-metathesis reaction of functionalized and substituted olefins using group 8 transition metal carbene complexes as metathesis catalysts
01/02/2004EP1372632A1 Proliferative activator receptor (ppar) compounds
01/02/2004EP1372620A2 Methods for restoring cognitive function following systemic stress
01/02/2004EP1372594A1 Water-in-stable kojic acid derivatives and method for preparing thereof, and whitening cosmetics composition containing the same
01/01/2004US20040002601 Method for producing cephalosporins
01/01/2004US20040002595 Nucleic acid labeling compounds
01/01/2004US20040002539 Enzyme inhibitors; anticoagulants; blood collecting device
01/01/2004US20040002506 Antiproliferative agents; antitumor agents
01/01/2004US20040002489 Process and intermediates for making non-nucleoside HIV-1 reverse transcriptase inhibitors
01/01/2004US20040002480 Aminobutyric acid derivatives and pharmaceutical composition containing the same as active ingredient
01/01/2004US20040002479 Proteasome inhibitors; bone disorders
01/01/2004US20040002478 Ligands for metabotropic glutamate receptors and inhibitors of NAALADase
01/01/2004US20040002123 Detection of transmembrane potentials by optical methods
01/01/2004US20040002002 Material for electrolytic solutions and use thereof
12/2003
12/31/2003WO2004001882A1 Supporting electrolyte for cell and method for production thereof, and cell
12/31/2003WO2004000922A1 Low acidity phosphate esters
12/31/2003WO2004000854A1 Sulfur-containing phospholipid derivatives
12/31/2003WO2004000814A1 8-(biaryl) quinoline pde4 inhibitors
12/31/2003WO2004000809A1 Cationic alkoxyamines and their use in producing nano particles from natural or synthetic clays
12/31/2003WO2004000805A1 Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof
12/31/2003WO2004000782A1 Preparation method of valienamine from acarbose and/or acarbose derivatives using trifluoroacetic acid
12/31/2003WO2004000774A1 Diaryliodonium salt catalysts made from iodotoluene and a method for preparing them
12/31/2003WO2003078627A3 A building block capable of functional entity transfer to nucleophil
12/31/2003WO2003072576A3 Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them
12/31/2003WO2003063758A3 Bicyclic cb2 cannabinoid receptor ligands
12/31/2003WO2003000188A3 Novel quinazolines and uses thereof
12/31/2003CN1463798A Chirality catalyst for oxygenized dinaphthol
12/31/2003CN1133224C Heterolamellar photovoltaic films
12/31/2003CN1132839C Process for manufacture of bis (phosphine oxide)- and bis (phosphonate) -compounds
12/31/2003CN1132838C Process for preparing N,N-diacetate aminomethylene phosphoric acid (diglycerophosphine)
12/31/2003CN1132833C Vinyl-pyrrolidone cynnematin with alkali subtituent
12/31/2003CN1132831C 液体噻吨酮光引发剂 Liquid thioxanthone photoinitiators
12/31/2003CN1132676C 用于降低血制品中小有机分子的方法和装置 For reducing blood products of small organic molecules method and apparatus
12/31/2003CA2490121A1 Modified phospholipids
12/31/2003CA2490112A1 Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof